Pennant Group (PNTG)

• Market cap: $844M
• 1 day: -6.24%
• 5 days: -4.30%
• 1 month: 4.70%
• 3 months: -12.22%
• 6 months: -25.42%
• Year to date: -7.41%
• 1 year: 17.51%
• 5 years: 46.97%
• 10 years: 62.36%
• Sector: Healthcare
• Industry: Medical Care Facilities

About: Pennant Group Inc is engaged in providing healthcare services to patients of all ages, including the growing senior population, in the United States. It operates in multiple lines of business including home health, hospice, and senior living which includes the company's assisted living, independent living, and memory care communities across Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The company generates majority of its revenue from home health and hospice services segment, which includes its home health, hospice and home care businesses.

Employees: 7,000

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

525% more call options, than puts

Call options by funds: $713K | Put options by funds: $114K

46% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 24

44% more repeat investments, than reductions

Existing positions increased: 72 | Existing positions reduced: 50

5% more funds holding

Funds holding: 171 [Q3] → 179 (+8) [Q4]

1.8% more ownership

Funds ownership: 86.46% [Q3] → 88.27% (+1.8%) [Q4]

14% less capital invested

Capital invested by funds: $931M [Q3] → $804M (-$127M) [Q4]

50% less funds holding in top 10

Funds holding in top 10: 6 [Q3] → 3 (-3) [Q4]

Research analyst outlook

3 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $28 14% upside
• Avg. target: $35 41% upside
• High target: $38 55% upside

3 analyst ratings

• positive: 2 67%
• neutral: 1 33%
• negative: 0 0%

Stephens & Co. Raj Kumar 57% 1-year accuracy 4 / 7 met price target	55% upside $38	Overweight Reiterated	2 Apr 2025
Stephens & Co. Scott Fidel 49% 1-year accuracy 20 / 41 met price target	55% upside $38	Overweight Reiterated	11 Mar 2025
Truist Securities David Macdonald 60% 1-year accuracy 60 / 100 met price target	14% upside $28	Hold Maintained	7 Mar 2025